Conway Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.6K | Hold |
10,000
| – | – | 0.02% | 49 |
|
|
2025
Q1 | $37.6K | Hold |
10,000
| – | – | 0.02% | 43 |
|
|
2024
Q4 | $58.3K | Hold |
10,000
| – | – | 0.03% | 48 |
|
|
2024
Q3 | $119K | Hold |
10,000
| – | – | 0.06% | 47 |
|
|
2024
Q2 | $108K | Hold |
10,000
| – | – | 0.05% | 41 |
|
|
2024
Q1 | $113K | Sell |
10,000
-16,500
| -62% | -$187K | 0.06% | 45 |
|
|
2023
Q4 | $372K | Hold |
26,500
| – | – | 0.24% | 34 |
|
|
2023
Q3 | $327K | Hold |
26,500
| – | – | 0.24% | 31 |
|
|
2023
Q2 | $239K | Hold |
26,500
| – | – | 0.17% | 41 |
|
|
2023
Q1 | $92K | Hold |
26,500
| – | – | 0.08% | 46 |
|
|
2022
Q4 | $64.9K | Hold |
26,500
| – | – | 0.07% | 43 |
|
|
2022
Q3 | $73.1K | Hold |
26,500
| – | – | 0.07% | 48 |
|
|
2022
Q2 | $108K | Hold |
26,500
| – | – | 0.1% | 47 |
|
|
2022
Q1 | $113K | Sell |
26,500
-5,774
| -18% | -$24.6K | 0.07% | 57 |
|
|
2021
Q4 | $302K | Hold |
32,274
| – | – | 0.18% | 46 |
|
|
2021
Q3 | $889K | Sell |
32,274
-10,000
| -24% | -$276K | 0.6% | 31 |
|
|
2021
Q2 | $1.18M | Buy |
+42,274
| New | +$1.18M | 0.81% | 29 |
|